Renaissance Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-64,400	Closed	-$5.64M	–	3357
2018 Q3	$5.64M	Sell	64,400 -311,000	-83%	-$31.3M	0.01%	1726
2018 Q2	$37M	Buy	375,400 +140,000	+59%	+$13.9M	0.04%	579
2018 Q1	$28M	Buy	235,400 +227,300	+2,806%	+$29.3M	0.03%	746
2017 Q4	$1.03M	Buy	+8,100	New	+$1.02M	﹤0.01%	2651
2017 Q2	–	Sell	-51,100	Closed	-$2.62M	–	3175
2017 Q1	$2.62M	Buy	+51,100	New	+$2.36M	﹤0.01%	2094
2016 Q3	–	Sell	-18,673	Closed	-$1.04M	–	3305
2016 Q2	$1.04M	Sell	18,673 -195,327	-91%	-$12.3M	﹤0.01%	2518
2016 Q1	$13.4M	Buy	+214,000	New	+$14.2M	0.03%	929
2015 Q3	–	Sell	-102,399	Closed	-$12.3M	–	3143
2015 Q2	$12.3M	Buy	+102,399	New	+$12.2M	0.03%	816
2014 Q2	–	Sell	-158,700	Closed	-$10.7M	–	2763
2014 Q1	$10.7M	Buy	+158,700	New	+$12.3M	0.03%	827